Invitrogen Corporation (Invitrogen) is a developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products. The... more

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its pipeline... more

CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more

Exelixis, Inc. is a biotechnology company engaged in the development of differentiated pharmaceutical products for the treatment of cancer and other serious diseases. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer, renal disease... more

ExonHit Therapeutics is a worldleading company in developing novel pharmaceuticals and diagnostics from its unique understanding of alternative RNA splicing, the process by which a single gene can lead to several proteins. The company's proprietary gene profiling technology DATASÔ, allows... more

Galapagos is a drug discovery company with two operating divisions: drug discovery and BioFocus DPI, Galapagos' service division. Galapagos' drug discovery division aims to develop novel, disease-modifying drugs in selected bone and joint disease areas for which there is a need for safe... more

Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: Albuferon for chronic hepatitis C, LymphoStat-B for systemic lupus erythematosus and ABthraxtm for inhalation anthrax. All three of these... more

Gene Logic, headquartered in Gaithersburg, Md., has developed proprietary genomics databases and services to enable customers worldwide to discover and prioritize drug targets, identify biomarkers, predict toxicity, understand mechanisms of toxicity, and obtain insights into the efficacy... more

GPC Biotech AG is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. Unlike other platinum-based drugs,... more

A: EraGen was founded in 1994 as Sulfonics, Inc., a California corporation. It changed its name to EraGen Biosciences and was reincorporated in Delaware in 1999. In 2002 the company consolidated its operations from Florida to new facilities in Madison, Wisconsin. Q: How large is EraGen?... more

BioVex is a biotechnology company focused on the development of novel biologics for the treatment of cancer and infectious disease. Our lead product for the treatment of cancer is OncoVEXGM-CSF. OncoVEXGM-CSF is in Phase II clinical development and is currently being tested in clinical... more

Lexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company focused on discovering and developing treatments for human disease. The Company uses its proprietary gene knockout technology to identify and develop new drugs. In its Genome5000 program, Lexicon is utilizing its... more

Acadia Pharmaceuticals Inc. (Acadia Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company has six programs in clinical development and several... more

Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company that discovers and develops small molecule drugs for the treatment of inflammatory/autoimmune diseases, cancer and viral diseases. The Company's research focuses on intracellular signalling pathways and... more

Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. In July 2007, the Company initiated a Phase I clinical trial in the United Kingdom with its lead candidate in clinical development, ATHX-105, for the treatment of... more

VistaGen Therapeutics, headquartered in South San Francisco, CA, is a leader in the rapidly expanding field of embryonic stem cell (ES Cell) technologies as an in vitro platform for predictive toxicology and drug discovery. The company's industry advantage is built around the use of its... more

Dyadic International, Inc. (Dyadic) is a global biotechnology company that uses its technologies (the Dyadic Platform Technology) to conduct research and development activities for the discovery, development, and manufacture of products and enabling solutions to the bioenergy, industrial... more

Sangamo BioSciences, Inc. (Sangamo) is engaged in the development and commercialization of transcription factors for gene regulation and gene modification. Sangamo’s gene regulation and gene modification technology platform is enabled by the engineering of a class of transcription factors... more

Isis Pharmaceuticals, Inc. (Isis) is a biopharmaceutical company engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. In addition to its antisense programs, the Company maintains technology leadership beyond its core areas of focus through... more

Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by KinobeadsÔ, a proprietary technology for the screening and profiling of kinases in relevant... more

Biosource International, Inc. is a broad based life sciences company focused on providing solutions in the areas of functional proteomics and advanced drug discovery through the development, manufacturing, marketing, and distribution of unique biologically active reagent systems which... more

Founded in 1997, Genedata is a Swiss-based company with headquarters in Basel. We also maintain subsidiaries and branch offices in Munich (Germany), Konstanz (Germany), Boston (USA), San Francisco (USA) and Tokyo (Japan).

DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders. The Company's most advanced drug candidate is Somatoprim, a potentially best-in-class somatostatin analogue for the... more

Paradigm Genetics is a biotechnology company applying its proprietary systems biology platform to the discovery of safer, more effective drugs and agrichemicals. Paradigm Genetics has major collaborations with the National Institute of Environmental Health Sciences, Bayer CropScience, the... more

Immusol is a private biotechnology company located in San Diego, California. The company currently employs approximately 50 employees, 90% of whom are focused on Research and Development. Immusol has built a management team with considerable combined experience in drug discovery and... more

Interleukin Genetics, Inc. (Interleukin) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the personalized health market. The Company has two primary segments to its business. The first is a personalized health... more

Large Scale Biology Corporation's (LSBC) goal is to develop, manufacture and commercialize plant-made pharmaceutical proteins and vaccines. LSBC has successfully garnered an international reputation as an innovator in biomanufacturing. Driven by its unique GENEWARE® RNA plant viral gene... more

U.S. Genomics has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company's innovative technologies address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring. Addressable segments of these markets... more

Deltagen is a leading provider of drug discovery tools and services to the biopharmaceutical industry. Deltagen offers a suite of programs designed to enhance the efficiency of drug discovery including access to biological models as well as both small-molecule and secreted protein drug... more

Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of cardiometabolic diseases, and related disorders, including type II diabetes, atherosclerosis, dyslipidemia and obesity. The Company works in... more

Founded in 2000, Sagres Discovery is a biotech company that concentrates on the development of therapeutics in the oncology field. Earlier this year it acquired San Diego-based MemRx Corp. Last winter Sagres arranged significant financial and research support from a large German... more

Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop, and commercialize novel therapeutic and diagnostic products for cancer and diseases of the central nervous system and cancer. The Company's core technologies exploit changes in disease-relevant proteins by altered... more

Exiqon A/S is a Denmark-based company active in the pharmaceutical industry. It is a provider of gene expression analysis products for the life sciences. The Company’s product portfolio includes the miRCURY LNA product line for microRNA research. It has also developed its proprietary... more

PerkinElmer Life Sciences is a leading global provider of drug discovery, research, and genetic disease screening solutions for customers in a variety of businesses, including the academic, biotechnology, clinical, and pharmaceutical industries. In addition to our position as the... more

Nautilus Biotech is a leading drug discovery and development company with a novel pipeline of next-generation therapeutic proteins with superior pharmacological profiles. The Company's protein engineering technology improves the characteristics of protein drugs, advancing drug stability... more

Proligo LLC, headquartered in Boulder, Colorado, a wholly owned subsidiary of Degussa. Proligo is building the premier nucleic acid chemical supply enterprise. The company is the leading supplier of key ingredients for oligonucleotide manufacturers, supplies innovative specialties for... more

ChondroGene Limited is a molecular diagnostics company that is developing proprietary blood-based molecular diagnostic tests for diseases with unmet clinical needs and significant commercial opportunities. The tests are based on the Company's breakthrough Sentinel Principle and are being... more

Mendel Biotechnology was founded in early 1997 based on the idea that controlling gene expression would create new opportunities to improve plant productivity and quality. From 1997-2003, we focused on understanding the functions of a large class of genes called transcription factors,... more

Packard BioScience, headquartered in Meriden, Connecticut, has approximately 1,000 employees and sales in 60 countries supported through its offices in North America, Europe and Asia. The company, which expects revenues of approximately $200 million in 2001, has strategic alliances with a... more

NEN Life Science Products is a provider of fluorescent , chemiluminescent and radioactive labeling and detection products for life science research , drug discovery , and genomics applications. For further information , contact : NEN Life Science Products , Inc. , 549 Albany Street ,... more

Eos Biotechnology, Inc. is a genomics company, dedicated to translating biology into societal and commercial benefit. The Company is biology-driven and enabled by genomics-based technologies for the discovery, selection and validation of new drugs and drug targets.

Scion Pharmaceuticals, Inc. discovers and develops small molecule drugs that selectively regulate ion channels, a well-established class of pharmaceutical targets with potential application for a wide range of major diseases. Scion applies an innovative ion channel drug discovery strategy... more

Divergence, a world leader in the application of comparative and functional genomics to agriculture and infectious disease, is dedicated to the discovery of highly effective and ecologically sound strategies for parasite control. The Company's initial focus is on the critical unmet... more

Senesco Technologies, Inc. is a development-stage company. The Company along with its wholly owned subsidiary, Senesco, Inc., is engaged in utilizing eucaryotic translation initiation Factor 5A and deoxyhypusine synthase (DHS), in human health applications to develop approaches to treat... more

Paradigm Therapeutics was founded in 1999 and has established world class target identification and validation capabilities based on gene knock out technology and in vivo pharmacology. The acquisition of Amedis Pharmaceuticals in January 2005 added key medicinal chemistry skills. The... more

GenOdyssee is a drug discovery company using a unique, IP-protected approach to discovery of superior protein products. GenOdyssee discovers natural variants of proteins with higher efficacy and safety than marketed versions of the same therapeutic proteins. This approach is ideal for... more

Elitra is a leader in antimicrobial functional genomics and is focused on the identification, development and commercialization of novel antimicrobial compounds that target essential gene products of pathogenic organisms. The Company employs ultra-rapid proprietary techniques for the... more

Established in 1996, Amplicon Express Inc. is a privately held molecular biology service company based in the United States that provides powerful tools to tackle genome research. Amplicon Express is a world leader in BAC library construction and offers a full suite of complementing... more

Agilix Corporation is a leading developer of next generation functional genomics and proteomics platform technologies for the systematic discovery and analysis of genes, their protein products and related biological functions. Our technologies and services help reduce the risk, cost and... more